Enveric Biosciences's EBIT per Share for the
three
months ended in Sep. 2024 was $-3.59.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-44.47.
During the past 3 years, the average EBIT per Share Growth Rate was 45.90% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 55.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Enveric Biosciences's EBIT per Share or its related term are showing as below:
ENVB'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 43 Med: 45.9 Max: 68
Current: 45.9
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Enveric Biosciences was 68.00% per year. The lowest was 43.00% per year. And the median was 45.90% per year.
ENVB's 3-Year EBIT Growth Rate is ranked better than 91.05% of 1218
companies
in the Biotechnology industry
Industry Median: 5.9
vs ENVB: 45.90
Enveric Biosciences EBIT per Share Historical Data
The historical data trend for Enveric Biosciences's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-44.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enveric Biosciences (NAS:ENVB) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Enveric Biosciences EBIT per Share Related Terms
Thank you for viewing the detailed overview of Enveric Biosciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders. The company's lead program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. Enveric is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, being studied as a treatment of psychiatric disorders.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ENVB has been successfully added to your 